An ELISA method for the determination of circulating specific HSV-TAA antibodies has recently become available (TAF test). The presence of TAF was tested in serum of 154 patients with primary esophageal carcinoma, collected in three institutions. The overall TAF-test positivity rate was 57.1%, being significantly lower in stage IV than in stage III patients. The concordance rate between TAF and CEA, ferritin, TPA, SCC and TATI was low, suggesting that TAF is probably independent of the other tumor markers evaluated.
The clinical role of TAF-test determination in patients with esophageal carcinoma is currently under evaluation.
RawlsW.F., TompkinsW.A.F., FigueroaM.F., MelnickJ.L.. Herpes virus type 2: association with carcinoma of the cervix.Science1968; 161: 1255–6.
2.
RawlsW.F., TompkinsW.A.F., MelnickJ.L.. The association of herpes virus type 2 and carcinoma of uterine cervix.Am J Epidemiol1969; 89: 547–54.
3.
NahmiasA.J., NaibZ.M., JoseyW.E.. Herpes-virus homonis type 2 infection - Association with cervical cancer and perinatal disease.Perspect Virol1970; 7: 73–89.
4.
SabinA.B., TarroG.. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.Proc Nat Acad Sci USA1973; 70: 3225–9.
5.
MelnickJ.L., AdamE., RawlsW.E.. The causative role of herpes virus type 2 in cervical cancer.Cancer1974; 34: 1375–85.
6.
TarroG.. The role of herpes simplex virus in the neoplastic pathologies and diagnostic markers.J Exp Clin Cancer Res1985; 4: 213–24.
7.
AdamE., LevyA.H., RawlsW.E., MelnickJ.L.. Seroepid-emiologic studies of herpes virus type 2 and carcinoma of the cervix. I: case-control matching.J Natl Cancer Inst1971; 47: 941–51.
8.
HollinsheadA.C., ChretienP.B., LeeO.. In vivo and in vitro measurements of the relationship of human squamous carcinoma to herpes simplex virus tumor associated antigens.Cancer Res1976; 36: 557–64.
9.
NotterM.F.D., DochertyJ.J.. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigen.J Natl Cancer Inst1976; 57: 483–8.
10.
ShillitoeE.J., TarroG.. Lehner T. Cell-mediated immunity to herpes simplex virus type 1 and 2 antigens in leukoplakia and carcinoma in man.Oncology1976; 33: 192–5.
11.
CocchiaraR., TarroG., FlaminioG., Di GioiaM., Smer-agliaR., GeraciD.. Purificatiuon of herpes simplex virus- tumor associated antigen.Cancer1980; 46: 1594–601.
12.
CocchiaraR., TarroG., FlaminioG., GeraciD.. Correlation between immune complexes and herpes simplex virus (HSV)-tumor associated antigen (TAA) in human cancer sera.Cell & Mol Biol1983; 29: 397–403.
13.
TarroG., SabinA.B.. Nonvirion antigens produced by herpes simplex viruses 1 and 2.Proc Nat Acad Sci USA1973; 70: 1032–6.
14.
HollinsheadA.C., LeeO., ChretienP.B., TarpleyJ.L., RawlsW.E., AdamA.C.. Antibodies to herpes virus nonvirion antigens in squamous carcinomas.Science1973; 182: 713–5.
15.
HollinsheadA.C., TarroG., FosterW.A., SeigelL.J., Jaf-fursW.. Studies of tumor-specific and herpes virus nonvirion antigens.Cancer Res1974; 34: 1122–5.
AnzaiT., DreesmanG.R., CourtneyR.J., AdamR., RawlsW.E., MelnickB.M.. Antibody to HSV-type 2 induced non structural proteins in women with cervical cancer and in control groups.J Natl Cancer Inst1975; 54: 1051–9.
18.
CocchiaraR., TarroG., FlaminioG., Di GioiaM., GeraciD.. Purification of herpex simplex virus tumor associated antigen from human kidney carcinoma.Cancer1980; 46: 1594–1601.
19.
CocchiaraR., TarroG., FlaminioG., Di GioiaM.. Geraci D. Enzyme-linked immunosorbent assay for herpes simplex virus-tumor associated antigen.Cancer1980; 45: 938–42.
20.
SiracusanoF., TarroG., BivianoD., FlaminioG., SaladinoI., PiccoloA.. TAF test; a tumor diagnosis device in oncologic urology.Cancer1982; 50: 2215–7.
21.
TacconeW., BelliM.. Riccio M, TAF test: a new tumor marker?J Nucl Allied Sci1990; 34: 55–8.
AdamE.R., KaufmanR.H., MarcusR.L., RawlsW.E.. Seroepidemiological studies of Herpex Simplex Virus type 2 and carcinoma of the cervix.Dysplasia and carcinoma in situ. Am J Epidemiol1973; 98: 77–84.
24.
AlexanderJ.C.Jr., ChretienP.B., DellonA.L., SnyderJ.. CEA levels in patients with carcinoma of esophagus.Cancer1978; 42: 1492–7.
25.
GionM., TremoladaC., MioneR.. Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagus.Tumori1989; 75: 489–93.
26.
EliasD., LasserP., EschwegeF.. The treatment of epidermoid carcinoma of the esophagus.Ann Chir1984; 38: 234–45.
